Literature DB >> 7773928

Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.

S Kikuchi1, O Wada, T Nakajima, T Nishi, O Kobayashi, T Konishi, Y Inaba.   

Abstract

BACKGROUND: Helicobacter pylori is recognized as one of the possible causes of gastric carcinoma. There have been few studies on the relationship between H. pylori and gastric carcinoma in patients younger than 40 years.
METHODS: Data and sera were collected from the cases (105 hospitalized patients younger than 40 years with gastric carcinoma from 9 hospitals in the Kanto-Shin-Etsu Area in Japan) and controls (102 hospitalized control subjects and 101 screening control subjects) whose sex and age (within 4 years) were matched. The serum anti-H. pylori immunoglobulin G antibody was measured, and the odds ratio (OR) for the association between seropositivity and gastric carcinoma was calculated.
RESULTS: The OR (95% confidence interval) was 13.3 (5.3-35.6). For women, the OR was 32.8, whereas for men it was 6.8. The OR for patients with early gastric carcinoma was 20.8, and for patients with advanced disease, it was 10.8. The OR for intestinal-type carcinoma was 18.0, and for diffuse-type carcinoma, it was 12.8. The OR for proximal carcinoma was 11.3, and for distal carcinoma it was 14.8.
CONCLUSION: The OR for these young subjects was considerably larger than that for the older subjects in previously published studies. Among those younger than 40 years of age, early stage carcinoma has a stronger association with H. pylori than advanced carcinoma, and intestinal- and diffuse-type carcinomas have an association with H. pylori.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773928     DOI: 10.1002/1097-0142(19950615)75:12<2789::aid-cncr2820751202>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  52 in total

1.  Gender-associated differences in urea breath test for Helicobacter pylori infection referrals and results among dyspeptic patients.

Authors:  Menachem Moshkowitz; Noya Horowitz; Anat Beit-Or; Zamir Halpern; Erwin Santo
Journal:  World J Gastrointest Pathophysiol       Date:  2012-06-15

2.  Enhancement by monochloramine of the development of gastric cancers in rats: a possible mechanism of Helicobacter pylori-associated gastric carcinogenesis.

Authors:  H Iishi; M Tatsuta; M Baba; T Mikuni; R Yamamoto; K Iseki; H Yano; H Uehara; A Nakaizumi
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 3.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

4.  Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Authors:  S Miehlke; C Kirsch; B Dragosics; M Gschwantler; G Oberhuber; D Antos; P Dite; J Läuter; J Labenz; A Leodolter; P Malfertheiner; A Neubauer; G Ehninger; M Stolte; E Bayerdörffer
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

5.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

6.  Evaluation of a Novel Stool Antigen Rapid Test Kit for Detection of Helicobacter pylori Infection.

Authors:  Toshihiko Kakiuchi; Masumi Okuda; Kazutoshi Hashiguchi; Ichiro Imamura; Aiko Nakayama; Muneo Matsuo
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

7.  Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.

Authors:  Taiji Akamatsu; Shinya Ichikawa; Sadahide Okudaira; Shuichi Yokosawa; Yugo Iwaya; Tomoaki Suga; Hiroyoshi Ota; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-08-19       Impact factor: 7.527

8.  Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.

Authors:  Arto Kokkola; Johanna Louhimo; Pauli Puolakkainen; Henrik Alfthan; Caj Haglund; Hilpi Rautelin
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

9.  Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years.

Authors:  Gotaro Masuda; Akira Tokunaga; Takashi Shirakawa; Akiyoshi Togashi; Teruo Kiyama; Shunji Kato; Norio Matsukura; Hideki Bou; Masanori Watanabe; Takashi Tajiri
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

10.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.